(NASDAQ: TNDM) Tandem Diabetes Care's forecast annual revenue growth rate of 10.67% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Tandem Diabetes Care's revenue in 2024 is $747,718,000.On average, 6 Wall Street analysts forecast TNDM's revenue for 2024 to be $55,606,424,536, with the lowest TNDM revenue forecast at $55,205,550,137, and the highest TNDM revenue forecast at $55,917,646,932. On average, 6 Wall Street analysts forecast TNDM's revenue for 2025 to be $61,632,797,982, with the lowest TNDM revenue forecast at $59,284,519,335, and the highest TNDM revenue forecast at $62,854,847,966.
In 2026, TNDM is forecast to generate $66,183,129,317 in revenue, with the lowest revenue forecast at $59,284,519,335 and the highest revenue forecast at $70,028,320,747.